← Back to Clinical Trials
Recruiting NCT07186699

NCT07186699 Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07186699
Status Recruiting
Phase
Sponsor University of Southern California
Condition Lung Non-Small Cell Carcinoma
Study Type OBSERVATIONAL
Enrollment 45 participants
Start Date 2025-09-29
Primary Completion 2027-09-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Non-Interventional Study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 45 participants in total. It began in 2025-09-29 with a primary completion date of 2027-09-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Eligibility Criteria

Inclusion Criteria: * \* Adults ≥ 18 years of age * Histopathologic or cytologic diagnosis of NSCLC * Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy) * History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis * Ability to understand and the willingness to sign a written informed consent * English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent Exclusion Criteria: * Patients with cognitive disability unable to maintain 30-60 minute conversation

Contact & Investigator

Principal Investigator

Brooks V Udelsman

PRINCIPAL INVESTIGATOR

University of Southern California

Frequently Asked Questions

Who can join the NCT07186699 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Non-Small Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07186699 currently recruiting?

Yes, NCT07186699 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.

Where is the NCT07186699 trial being conducted?

This trial is being conducted at Los Angeles, United States, Los Angeles, United States.

Who is sponsoring the NCT07186699 clinical trial?

NCT07186699 is sponsored by University of Southern California. The principal investigator is Brooks V Udelsman at University of Southern California. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology